首页> 美国卫生研究院文献>Cancer Medicine >Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma

【2h】

Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma

机译：与舒尼替尼耐药相关的长非编码RNA的遗传变异预测肾细胞癌患者的风险和生存

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveLncARSR (lncRNA Activated in RCC with Sunitinib Resistance, ENST00000424980) is a newly identified lncRNA to promote the sunitinib resistance of renal cell carcinoma (RCC), which may contribute to tumorigenesis and progression. This study aimed to explore the association of lncARSR tagSNPs with the risk and prognosis of RCC.

机译：ObjectiveLncARSR（在具有Sunitinib耐药性的RCC中激活的lncRNA，ENST00000424980）是一种新发现的可促进肾细胞癌（RCC）的舒尼替尼耐药性的lncRNA，可能有助于肿瘤发生和发展。本研究旨在探讨lncARSR tagSNPs与RCC的风险和预后的关系。

著录项

期刊名称 Cancer Medicine
作者
Qianwei Xing; Ran Li; Aiming Xu; Zhiqiang Qin; Jinyuan Tang; Lei Zhang; Min Tang; Peng Han; Wei Wang; Chao Qin; Mulong Du; Wei Zhang;
展开▼
作者单位

展开▼
年(卷),期 2019(8),6
年度 2019
页码 2886–2896
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词
LncARSR renal cell carcinoma SNPs;

机译：LncARSR;肾细胞癌;SNP;

相似文献

外文文献
中文文献
专利

1. Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma [J] . Qianwei Xing, Ran Li, Aiming Xu, Cancer Medicine . 2019 ,第6期

机译：与舒尼替尼耐药相关的长非编码RNA的遗传变异预测肾细胞癌患者的风险和生存
2. Validation of the mskcc and heng risk criteria models for predicting survival in patients with metastatic renal cell carcinoma treated with sunitinib [J] . KwonW.-A., ChoI.-C., YuA., Annals of surgical oncology . 2013 ,第13期

机译：用mskcc和heng风险标准模型预测舒尼替尼治疗转移性肾细胞癌患者的生存
3. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma [J] . Yuenan Liu, Gong Cheng, Ziwei Huang, Cell death & disease. . 2020 ,第7期

机译：长度非致rna snhg12通过上调CDCA3在肾细胞癌中促进肿瘤进展和晒碱性抗性
4. Computational Pathology Analysis of TissueMicroarrays Predicts Survival of Renal Clear Cell Carcinoma Patients [C] . Thomas J. Fuchs, Peter J. Wild, Holger Moch, International Conference on Medical Image Computing and Computer-Assisted Intervention;MICCAI 2008 . 2008

机译：组织芯片的计算病理分析预测肾透明细胞癌患者的生存。
5. Analysis of prognostic factors for the development of metastases and survival in renal cell carcinoma patients [D] . Cheng, Jed-Sian 2008

机译：肾细胞癌患者转移和存活的预后因素分析
6. MicroRNA Expression Profiling of Peripheral Blood Samples Predicts Resistance to First-line Sunitinib in Advanced Renal Cell Carcinoma Patients [O] . Angelo Gámez-Pozo, Luis M Antón-Aparicio, Cristina Bayona, 2012

机译：外周血样品的MicroRNA表达谱预测晚期肾细胞癌患者对一线舒尼替尼的耐药性
7. Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma [O] . Qianwei Xing, Ran Li, Aiming Xu, 2019

机译：遗传变异在与晒苦尼菌的长型RNA相关，预测肾细胞癌患者的风险和存活率

Genetic variants in a long noncoding RNA related to Sunitinib Resistance predict risk and survival of patients with renal cell carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅